PAVmed (PAVM) Net Cash Flow Growth (1y) (2016 - 2025)
PAVmed (PAVM) Net Cash Flow Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 76.43% |
| 10 | PAVmed | 10.85 Mn | 9.31 Mn | -4,000.00 | -460.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -460.48% |
| Jun 30, 2025 | 3,513.51% |
| Mar 31, 2025 | -74.31% |
| Dec 31, 2024 | 106.20% |
| Jun 30, 2024 | 99.69% |
| Mar 31, 2024 | -38.16% |
| Dec 31, 2023 | 60.28% |
| Sep 30, 2023 | -28.53% |
| Jun 30, 2023 | -3,012.74% |
| Mar 31, 2023 | 176.16% |
| Dec 31, 2022 | -142.69% |
| Sep 30, 2022 | -42.58% |
| Jun 30, 2022 | 107.80% |
| Mar 31, 2022 | -140.02% |
| Dec 31, 2021 | 345.35% |
| Sep 30, 2021 | -583.84% |
| Jun 30, 2021 | -223.20% |
| Mar 31, 2021 | 1,145.62% |
| Dec 31, 2020 | 322.38% |
| Sep 30, 2020 | 143.15% |